Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
2.81
Dollar change
-0.01
Percentage change
-0.35
%
Index- P/E- EPS (ttm)-1.47 Insider Own28.93% Shs Outstand27.29M Perf Week-2.43%
Market Cap76.68M Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float19.39M Perf Month-0.18%
Income-39.90M PEG- EPS next Q-0.27 Inst Own17.78% Short Float0.11% Perf Quarter5.24%
Sales75.33M P/S1.02 EPS this Y39.47% Inst Trans- Short Ratio0.41 Perf Half Y-12.46%
Book/sh-0.04 P/B- EPS next Y32.41% ROA-29.28% Short Interest0.02M Perf Year-28.32%
Cash/sh0.53 P/C5.29 EPS next 5Y- ROE-217.59% 52W Range2.15 - 4.64 Perf YTD-28.68%
Dividend Est.- P/FCF- EPS past 5Y21.65% ROI-105.24% 52W High-39.44% Beta0.56
Dividend TTM- Quick Ratio1.53 Sales past 5Y34.90% Gross Margin54.94% 52W Low30.70% ATR (14)0.14
Dividend Ex-Date- Current Ratio1.69 EPS Y/Y TTM47.07% Oper. Margin-33.83% RSI (14)50.20 Volatility5.60% 4.38%
Employees300 Debt/Eq- Sales Y/Y TTM- Profit Margin-52.97% Recom1.00 Target Price7.25
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q37.62% Payout- Rel Volume1.37 Prev Close2.82
Sales Surprise9.42% EPS Surprise-3.61% Sales Q/Q34.93% EarningsMay 08 AMC Avg Volume54.13K Price2.81
SMA20-0.09% SMA504.25% SMA200-8.39% Trades Volume74,337 Change-0.35%
Date Action Analyst Rating Change Price Target Change
May-31-23Initiated TD Cowen Outperform $7
Jul-18-22Resumed Oppenheimer Outperform $18
May-15-24 04:00PM
May-06-24 08:52AM
May-01-24 01:53PM
07:45AM
Mar-28-24 01:30PM
04:00PM Loading…
Mar-12-24 04:00PM
Mar-07-24 10:42AM
Mar-06-24 04:00PM
Feb-21-24 05:00PM
Feb-16-24 08:45AM
Jan-08-24 04:00PM
Dec-18-23 01:00AM
Nov-27-23 01:00AM
Nov-14-23 04:00PM
Nov-13-23 04:00PM
04:00PM Loading…
Nov-08-23 04:00PM
Nov-06-23 01:00AM
Oct-25-23 04:00PM
Oct-20-23 04:00PM
Oct-09-23 04:00PM
Oct-02-23 04:04PM
Sep-26-23 04:46PM
Aug-23-23 04:00PM
Aug-10-23 04:00PM
Aug-09-23 04:00PM
Aug-03-23 07:25PM
Jun-30-23 04:00PM
Jun-05-23 05:30PM
May-25-23 04:30PM
May-23-23 04:00PM
04:00PM Loading…
May-15-23 04:00PM
May-01-23 04:00PM
Apr-25-23 04:00PM
Apr-19-23 04:00PM
Apr-07-23 04:30PM
Mar-13-23 02:00AM
Mar-08-23 05:00PM
04:00PM
Mar-06-23 05:34PM
Mar-03-23 04:30PM
Feb-28-23 04:30PM
Feb-22-23 04:30PM
Feb-21-23 04:30PM
Feb-15-23 04:30PM
Feb-13-23 04:00PM
Feb-03-23 08:00AM
Feb-01-23 04:00PM
Jan-20-23 01:00AM
Jan-09-23 04:00PM
Dec-19-22 05:00PM
Nov-29-22 04:06PM
Nov-04-22 01:33PM
Oct-27-22 04:00PM
Aug-25-22 04:00PM
Aug-19-22 04:00PM
Aug-09-22 10:09AM
Aug-02-22 04:30PM
04:00PM
May-25-22 04:00PM
May-19-22 04:00PM
Apr-27-22 04:00PM
Apr-25-22 04:00PM
Mar-30-22 04:30PM
Mar-02-22 04:00PM
Feb-17-22 04:00PM
Feb-09-22 04:00PM
Dec-10-21 06:01PM
Nov-22-21 05:00PM
Nov-15-21 05:00PM
Nov-09-21 03:38PM
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.